moxifloxacin has been researched along with 2,3-dimercaptosuccinic acid in 1 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (2,3-dimercaptosuccinic acid) | Trials (2,3-dimercaptosuccinic acid) | Recent Studies (post-2010) (2,3-dimercaptosuccinic acid) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 7 | 0 | 0 |
| Protein | Taxonomy | moxifloxacin (IC50) | 2,3-dimercaptosuccinic acid (IC50) |
|---|---|---|---|
| tyrosine-protein phosphatase non-receptor type 11 isoform 1 | Homo sapiens (human) | 0.518 | |
| dual specificity protein phosphatase 3 | Homo sapiens (human) | 3.22 | |
| tyrosine-protein phosphatase non-receptor type 5 isoform a | Homo sapiens (human) | 19 | |
| tyrosine-protein phosphatase non-receptor type 22 isoform 1 | Homo sapiens (human) | 4.48 | |
| bifunctional UDP-N-acetylglucosamine pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase | Mycobacterium tuberculosis H37Rv | 180.92 | |
| large T antigen | Betapolyomavirus macacae | 75.87 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
1 other study(ies) available for moxifloxacin and 2,3-dimercaptosuccinic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |